{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:36:33Z","timestamp":1780472193707,"version":"3.54.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.yebeh.2020.107251","type":"journal-article","created":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T12:11:12Z","timestamp":1593087072000},"page":"107251","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Intracerebroventricular administration of N-type calcium channel blocker ziconotide displays anticonvulsant, anxiolytic, and sedative effects in rats: A preclinical and pilot study"],"prefix":"10.1016","volume":"111","author":[{"given":"Melika","family":"Zamani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Budde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hooman","family":"Bozorgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2020.107251_bb0005","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/00019052-200304000-00008","article-title":"The epidemiology of epilepsy revisited","volume":"16","author":"Sander","year":"2003","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.yebeh.2020.107251_bb0010","doi-asserted-by":"crossref","first-page":"821","DOI":"10.3171\/jns.2000.93.5.0821","article-title":"Neurobehavioral protection by the neuronal calcium channel blocker ziconotide in a model of traumatic diffuse brain injury in rats","volume":"93","author":"Berman","year":"2000","journal-title":"J Neurosurg"},{"key":"10.1016\/j.yebeh.2020.107251_bb0015","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1749-6632.1994.tb44407.x","article-title":"Calcium and excitotoxic neuronal injury","volume":"747","author":"Choi","year":"1994","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.yebeh.2020.107251_bb0020","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1371\/journal.pone.0023690","article-title":"Pharmacological activation\/inhibition of the cannabinoid system affects alcohol withdrawal induced neuronal hypersensitivity to excitotoxic insults","volume":"6","author":"Rubio","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.yebeh.2020.107251_bb0025","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.neuropharm.2012.07.026","article-title":"MDMA produces a delayed and sustained increase in the extracellular concentration of glutamate in the rat hippocampus","volume":"63","author":"Anneken","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.yebeh.2020.107251_bb0030","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/00004691-199703000-00002","article-title":"Hypothetical mechanisms for the cellular and neuro-physiologic basis of secondary epileptogenesis: proposed role of synaptic reorganization","volume":"14","author":"Dudek","year":"1997","journal-title":"J Clin Neurophysiol"},{"key":"10.1016\/j.yebeh.2020.107251_bb0035","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1146\/annurev.physiol.63.1.815","article-title":"On the cellular and network bases of epileptic seizures","volume":"63","author":"McCormick","year":"2001","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.yebeh.2020.107251_bb0040","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1046\/j.1528-1157.44.s10.2.x","article-title":"Prevention of epilepsy after head trauma: do we need new drugs or a new approach","volume":"44","author":"Benardo","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2020.107251_bb0045","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.tins.2006.08.006","article-title":"Presynaptic Ca2\u00fe channels-integration centers for neuronal signaling pathways","volume":"29","author":"Evans","year":"2006","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.yebeh.2020.107251_bb0050","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(10)60354-6","article-title":"Ziconotide for treatment of severe chronic pain","volume":"375","author":"Schmidtko","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.yebeh.2020.107251_bb0055","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2147\/nedt.2007.3.1.69","article-title":"Ziconotide: a review of its pharmacology and use in the treatment of pain","volume":"3","author":"McGivern","year":"2007","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.yebeh.2020.107251_bb0060","doi-asserted-by":"crossref","first-page":"35335","DOI":"10.1074\/jbc.M002252200","article-title":"Novel omega-conotoxins from Conus catus discriminate among neuronal calcium channel subtypes","volume":"275","author":"Lewis","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.yebeh.2020.107251_bb0065","first-page":"231","article-title":"Neuroprotective and cardioprotective conopeptides: an emerging class of drug leads","volume":"12","author":"Twede","year":"2009","journal-title":"Curr Opin Drug Discov Devel"},{"key":"10.1016\/j.yebeh.2020.107251_bb0070","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.bbamem.2013.01.019","article-title":"Mechanisms of conotoxin inhibition of N-type (Cav2.2) calcium channels","volume":"1828","author":"Adams","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.yebeh.2020.107251_bb0075","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3923\/jms.2006.1021.1024","article-title":"Anticonvulsant and anxiolytic effects of calcium channel blockers in mice","volume":"6","author":"Umukoro","year":"2006","journal-title":"J Med Sci"},{"key":"10.1016\/j.yebeh.2020.107251_bb0080","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.neuropharm.2007.05.030","article-title":"T-current related effects of antiepileptic drugs and a Ca2+ channel antagonist on thalamic relay and local circuit interneurons in a rat model of absence epilepsy","volume":"53","author":"Broicher","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.yebeh.2020.107251_bb0085","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00424-014-1454-x","article-title":"T-type calcium channel blockers as neuroprotective agents","volume":"466","author":"Kopecky","year":"2014","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.yebeh.2020.107251_bb0090","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0304-3959(99)00214-6","article-title":"Interactions of intrathecally administered ziconotide, a selective blocker of neuronal N-type voltage-sensitive calcium channels, with morphine on nociception in rats","volume":"84","author":"Wang","year":"2000","journal-title":"Pain"},{"key":"10.1016\/j.yebeh.2020.107251_bb0095","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/jama.291.1.63","article-title":"Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial","volume":"291","author":"Staats","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.yebeh.2020.107251_bb0100","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jpainsymman.2005.10.003","article-title":"A randomized, double-blind, placebo-controlled study of intrathecal ziconotide in adults with severe chronic pain","volume":"31","author":"Rauck","year":"2006","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.yebeh.2020.107251_bb0105","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1525-1403.2006.00055.x","article-title":"Intrathecal ziconotide in the treatment of chronic nonmalignant pain: a randomized, double-blind, placebo-controlled clinical trial","volume":"9","author":"Wallace","year":"2006","journal-title":"Neuromodulation"},{"key":"10.1016\/j.yebeh.2020.107251_bb0110","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1517\/13543776.8.10.1237","article-title":"N-type calcium channel blockers in pain and stroke","volume":"8","author":"Cox","year":"2005","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.yebeh.2020.107251_bb0115","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S0741-5214(99)70145-X","article-title":"The neuroprotective effects of intrathecal administration of the selective N-type calcium channel blocker ziconotide in a rat model of spinal ischemia","volume":"30","author":"Lindsay","year":"1999","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.yebeh.2020.107251_bb0120","first-page":"390","article-title":"Antidepressant-like and memory-enhancing effects of the N-type calcium channel blocker ziconotide in rats.","author":"Bozorgi","year":"2020","journal-title":"Behav Brain Res."},{"key":"10.1016\/j.yebeh.2020.107251_bb0125","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/15569543.2016.1181657","article-title":"The effect of intrathecal administration of the N-type calcium channels antagonist, \u03c9-conotoxin MVIIA, on attenuating the spontaneous and naloxone-precipitated morphine withdrawal in rats","volume":"35","author":"Bozorgi","year":"2016","journal-title":"Tox Rev"},{"key":"10.1016\/j.yebeh.2020.107251_bb0130","first-page":"1","article-title":"Neuronal calcium channels blocker, ziconotide (\u0277-conotoxin MVIIA), reverses morphine withdrawal-induced memory impairments via alteration in hippocampal NMDA receptor expression in rats","volume":"38","author":"Bozorgi","year":"2018","journal-title":"Tox Rev"},{"key":"10.1016\/j.yebeh.2020.107251_bb0135","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1210\/endo.138.7.5255","article-title":"Central oxytocin administration reduces stress-induced corticosterone release and anxiety behavior in rats","volume":"138","author":"Windle","year":"1997","journal-title":"Endocrinology"},{"key":"10.1016\/j.yebeh.2020.107251_bb0140","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.yhbeh.2007.10.012","article-title":"L-type calcium channel blockade attenuates morphine withdrawal: in vivo interaction between L-type calcium channels and corticosterone","volume":"53","author":"Esmaeili-Mahani","year":"2008","journal-title":"Horm Behav"},{"key":"10.1016\/j.yebeh.2020.107251_bb0145","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejphar.2012.08.022","article-title":"The effect of nimodipine on memory impairment during spontaneous morphine withdrawal in mice: corticosterone interaction","volume":"695","author":"Vaseghi","year":"2012","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.yebeh.2020.107251_bb0150","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1749-6632.2003.tb07096.x","article-title":"Neuroimaging studies of amygdala function in anxiety disorders","volume":"985","author":"Rauch","year":"2003","journal-title":"Ann N Y Sci"},{"key":"10.1016\/j.yebeh.2020.107251_bb0155","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0006-8993(00)02019-9","article-title":"Corticosterone delivery to the amygdala increases corticotropin-releasing factor mRNA in the central amygdaloid nucleus and anxiety-like behavior","volume":"861","author":"Shepard","year":"2000","journal-title":"Brain Res"},{"key":"10.1016\/j.yebeh.2020.107251_bb0160","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1152\/ajpendo.00233.2002","article-title":"Repeated ICV administration of oxyntomodulin causes a greater reduction in body weight gain than in pair-fed rats","volume":"283","author":"Dakin","year":"2002","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.yebeh.2020.107251_bb0165","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF00569658","article-title":"Reversal of the effect of centrally-administered diazepam on morphine antinociception by specific (Ro 15-1788 and Ro 15-3505) and non-specific (bicuculline and caffeine) benzodiazepine antagonists","volume":"333","author":"Zambotti","year":"1986","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.yebeh.2020.107251_bb0170","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0013-4694(72)90177-0","article-title":"Modification of seizure activity by electrical stimulation: II. Motor seizure","volume":"32","author":"Racine","year":"1972","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"10.1016\/j.yebeh.2020.107251_bb0175","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0091-3057(95)02126-4","article-title":"A review of the validity and variability of the elevated plus-maze as an animal model of anxiety","volume":"54","author":"Hogg","year":"1996","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.yebeh.2020.107251_bb0180","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0166-4328(96)00160-X","article-title":"Anxiety and activity-related effects of diazepam and chlordiazepoxide in the rat light\/dark and dark\/light tests","volume":"85","author":"Chaouloff","year":"1997","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.yebeh.2020.107251_bb0185","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/0006-3223(93)90121-S","article-title":"Indole-pyruvic acid, a tryptophan ketoanalogue, antagonizes the endocrine but not the behavioral effects of repeated stress in a model of depression","volume":"33","author":"Biagini","year":"1993","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.yebeh.2020.107251_bb0190","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0022-3565(25)13017-6","article-title":"Studies on Acorus calamus. III. Some pharmacological properties of the volatile oil","volume":"125","author":"Dandiya","year":"1959","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.yebeh.2020.107251_bb0195","first-page":"129","article-title":"Calcium channel blockers and neuroprotection","author":"Feuerstein","year":"2013","journal-title":"Emerg Strateg Neuroprotection"},{"key":"10.1016\/j.yebeh.2020.107251_bb0200","doi-asserted-by":"crossref","first-page":"680","DOI":"10.3390\/md11030680","article-title":"Omega-conotoxins as experimental tools and therapeutics in pain management","volume":"11","author":"Hannon","year":"2013","journal-title":"Mar Drugs"},{"key":"10.1016\/j.yebeh.2020.107251_bb0205","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1124\/jpet.107.125047","article-title":"Prolonged attenuation of amygdala-kindled seizure measures in rats by convection-enhanced delivery of the N-type calcium channel antagonists omega-conotoxin GVIA and omega-conotoxin MVIIA","volume":"323","author":"Gasior","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.yebeh.2020.107251_bb0210","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4103\/0253-7613.150324","article-title":"Evaluation of effects of T and N type calcium channel blockers on the electroencephalogram recordings in Wistar Albino Glaxo\/Rij rats, an absence epilepsy model","volume":"47","author":"Durmus","year":"2015","journal-title":"Indian J Pharmacol"},{"key":"10.1016\/j.yebeh.2020.107251_bb0215","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1021\/jm9902739","article-title":"Synthesis of a series of 4-benzyloxyaniline analogues as neuronal N-type calcium channel blockers with improved anticonvulsant and analgesic properties","volume":"42","author":"Hu","year":"1999","journal-title":"J Med Chem"},{"key":"10.1016\/j.yebeh.2020.107251_bb0220","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0149-7634(01)00002-1","article-title":"Corticosteroids in relation to fear, anxiety and psychopathology","volume":"25","author":"Korte","year":"2001","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.yebeh.2020.107251_bb0225","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.biopsych.2009.04.016","article-title":"Mineralocorticoid receptor over expression in basolateral amygdala reduces corticosterone secretion and anxiety","volume":"66","author":"Mitra","year":"2009","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.yebeh.2020.107251_bb0230","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/jcbfm.1995.75","article-title":"A selective N-type calcium channel antagonist reduces extracellular glutamate release and infarct volume in focal cerebral ischemia","volume":"15","author":"Takizawa","year":"1995","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.yebeh.2020.107251_bb0235","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1152\/physrev.00036.2003","article-title":"Molecular structure and physiological functions of GABA (B) receptors","volume":"84","author":"Bettler","year":"2004","journal-title":"Physiol Rev"},{"key":"10.1016\/j.yebeh.2020.107251_bb0240","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.coph.2005.01.013","article-title":"\u03b1-Conotoxins as selective probes for nicotinic acetylcholine receptor subclasses","volume":"5","author":"Janes","year":"2005","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.yebeh.2020.107251_bb0245","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1080\/01616412.1997.11740821","article-title":"Mitochondrial dysfunction after experimental and human brain injury and its possible reversal with a selective N-type calcium channel antagonist (SNX-lll)","volume":"19","author":"Verweij","year":"1997","journal-title":"Neurol Res"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505020304303?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505020304303?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:35:50Z","timestamp":1761503750000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505020304303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":49,"alternative-id":["S1525505020304303"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2020.107251","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intracerebroventricular administration of N-type calcium channel blocker ziconotide displays anticonvulsant, anxiolytic, and sedative effects in rats: A preclinical and pilot study","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2020.107251","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107251"}}